✦ LIBER ✦

A non-radioactive complement-dependent cytotoxicity assay for anti-CD20 monoclonal antibody

✍ Scribed by Hélène Gazzano-Santoro; Peter Ralph; Thomas C Ryskamp; Anthony B Chen; Venkat R Mukku

Book ID: 114051732
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 234 KB
Volume: 202
Category: Article
ISSN: 0022-1759
DOI: 10.1016/s0022-1759(97)00002-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An afucosylated anti-CD20 monoclonal ant

An afucosylated anti-CD20 monoclonal antibody with greater antibody-dependent cellular cytotoxicity and B-cell depletion and lower complement-dependent cytotoxicity than rituximab

✍ John R. Gasdaska; Steven Sherwood; Jeffrey T. Regan; Lynn F. Dickey 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 630 KB

Silencing of membrane complement inhibit

Silencing of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA enhances complement-dependent cytotoxicity of therapeutic anti-HER2 monoclonal antibodies

✍ Mamidi; Cinci; Kirschfink 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Combination of two anti-CD5 monoclonal a

Combination of two anti-CD5 monoclonal antibodies synergistically induces complement-dependent cytotoxicity of chronic lymphocytic leukaemia cells

✍ Klitgaard, Josephine L.; Koefoed, Klaus; Geisler, Christian; Gadeberg, Ole V.; F 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB

MICA is a target for complement-dependen

MICA is a target for complement-dependent cytotoxicity with mouse monoclonal antibodies and human alloantibodies

✍ Yizhou Zou; Fariba Mirbaha; Ana Lazaro; Yanzheng Zhang; Bhavna Lavingia; Peter S 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 457 KB

Synergistic cytotoxicity of iodine-131-a

Synergistic cytotoxicity of iodine-131-anti-CD20 monoclonal antibodies and chemotherapy for treatment of B-cell lymphomas

✍ Timothy A. Johnson; Oliver W. Press 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 231 KB

Preliminary clinical trials suggest that iodine-131 ( 131 I)labeled anti-CD20 monoclonal antibodies (MAbs) are effective single agents for the treatment of relapsed non-Hodgkin's B-cell lymphomas. However, despite high initial response rates, most patients treated in this manner will eventually rela

A screening assay for detecting CD8+ cel

A screening assay for detecting CD8+ cell non-cytotoxic anti-HIV responses

✍ M. Scott Killian; Sharon Ng; Carl E. Mackewicz; Jay A. Levy 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 291 KB